Esposito Susanna, Toni Giada, Tascini Giorgia, Santi Elisa, Berioli Maria Giulia, Principi Nicola
Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy.
Università degli Studi di Milano, Milan, Italy.
Front Endocrinol (Lausanne). 2019 Aug 28;10:592. doi: 10.3389/fendo.2019.00592. eCollection 2019.
Type 1 diabetes (T1D) is a chronic autoimmune disorder that leads to progressive pancreatic ß-cell destruction and culminates in absolute insulin deficiency and stable hyperglycaemia. It is very likely that environmental factors play a role in triggering islet autoimmunity. Knowing whether they have true relevance in favoring T1D development is essential for the effective prevention of the disease. Moreover, prevention could be obtained directly interfering with the development of autoimmunity through autoantigen-based immunotherapy. In this narrative review, the present possibilities for the prevention of T1D are discussed. Presently, interventions to prevent T1D are generally made in subjects in whom autoimmunity is already activated and autoantibodies against pancreatic cell components have been detected. Practically, the goal is to slow down the immune process by preserving the normal structure of the pancreatic islets for as long as possible. Unfortunately, presently methods able to avoid the risk of autoimmune activation are not available. Elimination of environmental factors associated with T1D development, reverse of epigenetic modifications that favor initiation of autoimmunity in subjects exposed to environmental factors and use of autoantigen-based immunotherapy are possible approaches, although for all these measures definitive conclusions cannot be drawn. However, the road is traced and it is possible that in a not so distant future an effective prevention of the disease to all the subjects at risk can be offered.
1型糖尿病(T1D)是一种慢性自身免疫性疾病,会导致胰腺β细胞进行性破坏,最终导致绝对胰岛素缺乏和持续性高血糖。环境因素很可能在引发胰岛自身免疫中起作用。了解它们是否与T1D的发展真正相关对于有效预防该疾病至关重要。此外,可以通过基于自身抗原的免疫疗法直接干预自身免疫的发展来实现预防。在这篇叙述性综述中,讨论了目前预防T1D的可能性。目前,预防T1D的干预措施通常是针对自身免疫已经被激活且已检测到针对胰腺细胞成分的自身抗体的受试者。实际上,目标是通过尽可能长时间地保持胰岛的正常结构来减缓免疫过程。不幸的是,目前尚无能够避免自身免疫激活风险的方法。消除与T1D发展相关的环境因素、逆转在暴露于环境因素的受试者中有利于自身免疫启动的表观遗传修饰以及使用基于自身抗原的免疫疗法都是可能的方法,尽管对于所有这些措施都无法得出明确结论。然而,道路已经明确,在不久的将来有可能为所有有风险的受试者提供该疾病的有效预防措施。